DEA's marijuana announcement keeps things the same
"The decision today is not surprising, given where they are with their studies."
Charles Houghton is a local attorney who deals mostly with marijuana cases, he says marijuana should never have been classified as a schedule one drug, and that now it will be hard to change that classification or ever legalize marijuana completely.
"They simply said they don't have enough evidence to take it off the schedule one list of drugs, simply because they didn't do the studies, they didn't do the studies because it was a schedule one drug," said Houghton.
Currently the University of Mississippi is the only research institution allowed to study marijuana. Companies like Colorado Spring's Realm of Caring would like to help with official studies but right now is only allowed to make observational research of clients using medicinal marijuana.
"Unfortunately it prohibits, and progress that we were hoping for especially easing restrictions on research and furthering the science on cannabis and how it can help," said Sam Riggio Realm of Caring Director of Operations.
The DEA says it will allow more research institutions to conduct studies on marijuana going forward. Advocates wanted full legalization, or at least making marijuana a schedule 2 drug.
"Taking marijuana off schedule one, may not be everything you expected it to be. There may be some unintended consequences, so you have to be careful what you ask for because you might just get it," said Houghton.
Schedule 2 would bring marijuana under FDA regulation and licensed pharmacists would administer it which could wreak havoc on the industry as it is today.
"Scheduling it as a schedule 1 drug was a mistake to start out with, it was based on politics and not science. getting it off of there again is going to be a matter of politics only hopefully this time with some science," said Houghton.